Living Well: New RSV Vaccine

After six decades of research, the world’s first vaccine to protect older adults against the respiratory syncytial virus, or RSV, has been green-lit by the U.S. Food and Drug Administration.

In today’s Living Well, brought to you by Springhill Pharmacy, News 40’s Michael Ridgway has more on what you need to know about this vaccine and others that may soon be on the way.